Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ADUS vs DBVT vs ALKS vs HCSG vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ADUS
Addus HomeCare Corporation

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.81B
5Y Perf.-1.7%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
HCSG
Healthcare Services Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.60B
5Y Perf.-6.7%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

ADUS vs DBVT vs ALKS vs HCSG vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ADUS logoADUS
DBVT logoDBVT
ALKS logoALKS
HCSG logoHCSG
PRGO logoPRGO
IndustryMedical - Care FacilitiesBiotechnologyBiotechnologyMedical - Care FacilitiesDrug Manufacturers - Specialty & Generic
Market Cap$1.81B$1712.35T$5.90B$1.60B$1.61B
Revenue (TTM)$1.45B$0.00$1.56B$1.84B$4.18B
Net Income (TTM)$100M$-168M$153M$59M$-1.82B
Gross Margin32.5%65.4%13.3%34.2%
Operating Margin9.8%12.3%3.0%-4.1%
Forward P/E14.1x24.8x20.8x5.6x
Total Debt$209M$22M$70M$25M$3.97B
Cash & Equiv.$82M$194M$1.12B$161M$532M

ADUS vs DBVT vs ALKS vs HCSG vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ADUS
DBVT
ALKS
HCSG
PRGO
StockMay 20May 26Return
Addus HomeCare Corp… (ADUS)10098.3-1.7%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Healthcare Services… (HCSG)10093.3-6.7%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ADUS vs DBVT vs ALKS vs HCSG vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ADUS and PRGO are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. DBVT, ALKS, and HCSG also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
ADUS
Addus HomeCare Corporation
The Income Pick

ADUS has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 0.58
  • Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
  • 399.9% 10Y total return vs ALKS's -11.0%
  • 23.2% revenue growth vs DBVT's -100.0%
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • 9.8% margin vs PRGO's -43.5%
Best for: sleep-well-at-night and defensive
HCSG
Healthcare Services Group, Inc.
The Niche Pick

HCSG is the clearest fit if your priority is efficiency.

  • 7.3% ROA vs DBVT's -89.0%
Best for: efficiency
PRGO
Perrigo Company plc
The Value Play

PRGO is the #2 pick in this set and the best alternative if value and dividends is your priority.

  • Lower P/E (5.6x vs 20.8x)
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: value and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthADUS logoADUS23.2% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 20.8x)
Quality / MarginsALKS logoALKS9.8% margin vs PRGO's -43.5%
Stability / SafetyADUS logoADUSBeta 0.58 vs DBVT's 1.26
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)HCSG logoHCSG7.3% ROA vs DBVT's -89.0%

ADUS vs DBVT vs ALKS vs HCSG vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ADUSAddus HomeCare Corporation
FY 2025
Personal Care
76.6%$1.1B
Hospice
18.5%$263M
Home Health
5.0%$71M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
HCSGHealthcare Services Group, Inc.
FY 2025
Dietary Services
55.1%$1.0B
Environmental Services
44.9%$825M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

ADUS vs DBVT vs ALKS vs HCSG vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 5 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$1.4B$0$1.6B$1.8B$4.2B
EBITDAEarnings before interest/tax$159M-$112M$212M$72M$58M
Net IncomeAfter-tax profit$100M-$168M$153M$59M-$1.8B
Free Cash FlowCash after capex$137M-$151M$392M$139M$108M
Gross MarginGross profit ÷ Revenue+32.5%+65.4%+13.3%+34.2%
Operating MarginEBIT ÷ Revenue+9.8%+12.3%+3.0%-4.1%
Net MarginNet income ÷ Revenue+6.9%+9.8%+3.2%-43.5%
FCF MarginFCF ÷ Revenue+9.5%+25.1%+7.6%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+7.7%+28.2%+6.6%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+17.2%+91.5%-4.1%+175.0%-56.4%
ALKS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 6 of 6 comparable metrics.

At 18.7x trailing earnings, ADUS trades at a 32% valuation discount to HCSG's 27.5x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than HCSG's 22.4x.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
Market CapShares × price$1.8B$1712.35T$5.9B$1.6B$1.6B
Enterprise ValueMkt cap + debt − cash$1.9B$1712.35T$4.9B$1.5B$5.1B
Trailing P/EPrice ÷ TTM EPS18.67x-0.76x24.76x27.54x-1.14x
Forward P/EPrice ÷ next-FY EPS est.14.12x20.83x5.56x
PEG RatioP/E ÷ EPS growth rate0.93x
EV / EBITDAEnterprise value multiple12.52x17.25x22.38x7.42x
Price / SalesMarket cap ÷ Revenue1.28x4.00x0.87x0.38x
Price / BookPrice ÷ Book value/share1.65x0.66x3.28x3.19x0.55x
Price / FCFMarket cap ÷ FCF17.48x12.28x11.49x11.12x
PRGO leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity+9.3%-130.2%+8.8%+11.8%-50.7%
ROA (TTM)Return on assets+7.0%-89.0%+5.4%+7.3%-19.8%
ROICReturn on invested capital+8.8%+18.9%+9.0%+3.7%
ROCEReturn on capital employed+10.9%-145.7%+14.2%+7.7%+4.3%
Piotroski ScoreFundamental quality 0–974774
Debt / EquityFinancial leverage0.19x0.13x0.04x0.05x1.35x
Net DebtTotal debt minus cash$127M-$172M-$1.0B-$136M$3.4B
Cash & Equiv.Liquid assets$82M$194M$1.1B$161M$532M
Total DebtShort + long-term debt$209M$22M$70M$25M$4.0B
Interest CoverageEBIT ÷ Interest expense14.45x-189.82x32.30x33.02x-7.20x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HCSG leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-8.7%+4.9%+25.3%+28.6%-13.5%
1-Year ReturnPast 12 months-13.4%+110.4%+16.5%+55.8%-51.2%
3-Year ReturnCumulative with dividends+16.3%+19.7%+14.5%+48.6%-58.1%
5-Year ReturnCumulative with dividends+0.0%-69.1%+60.9%-21.1%-60.1%
10-Year ReturnCumulative with dividends+399.9%-87.0%-11.0%-26.8%-77.7%
CAGR (3Y)Annualised 3-year return+5.2%+6.2%+4.6%+14.1%-25.2%
HCSG leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ADUS and ALKS each lead in 1 of 2 comparable metrics.

ADUS is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5000.58x1.26x1.06x1.12x1.18x
52-Week HighHighest price in past year$124.44$26.18$36.60$24.39$28.44
52-Week LowLowest price in past year$90.89$7.53$25.17$12.66$9.23
% of 52W HighCurrent price vs 52-week peak+78.2%+76.3%+96.7%+91.5%+41.2%
RSI (14)Momentum oscillator 0–10049.348.160.261.860.9
Avg Volume (50D)Average daily shares traded236K252K2.3M676K3.4M
Evenly matched — ADUS and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCSG leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ADUS as "Buy", DBVT as "Buy", ALKS as "Buy", HCSG as "Hold", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 9.8% for HCSG (target: $25). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricADUS logoADUSAddus HomeCare Co…DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHCSG logoHCSGHealthcare Servic…PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldHold
Price TargetConsensus 12-month target$128.67$46.33$44.00$24.50$20.00
# AnalystsCovering analysts1515281536
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises2002010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%+3.9%0.0%
HCSG leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HCSG leads in 2 (Total Returns, Analyst Outlook). 1 tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

ADUS vs DBVT vs ALKS vs HCSG vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ADUS or DBVT or ALKS or HCSG or PRGO a better buy right now?

For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.

2% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ADUS or DBVT or ALKS or HCSG or PRGO?

On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.

7x versus Healthcare Services Group, Inc. at 27. 5x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — ADUS or DBVT or ALKS or HCSG or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ADUS returned +399. 9% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ADUS or DBVT or ALKS or HCSG or PRGO?

By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.

58β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 119% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — ADUS or DBVT or ALKS or HCSG or PRGO?

By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.

2% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ADUS leads at 14. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ADUS or DBVT or ALKS or HCSG or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ADUS or DBVT or ALKS or HCSG or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — ADUS or DBVT or ALKS or HCSG or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. ADUS, DBVT, ALKS, HCSG do not pay a meaningful dividend and should not be held primarily for income.

09

Is ADUS or DBVT or ALKS or HCSG or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), +399. 9% 10Y return). Both have compounded well over 10 years (ADUS: +399. 9%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ADUS and DBVT and ALKS and HCSG and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ADUS is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while ADUS, DBVT, ALKS, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ADUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

HCSG

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.